AI Assistant
Blog
Pricing
Log In
Sign Up
A novel combination treatment with apremilast and tumor necrosis factor inhibitor for a patient with refractory intestinal Behcet’s disease
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.
